Cormedix Inc (CRMD)
5.455
+0.18
(+3.31%)
USD |
NASDAQ |
Apr 23, 16:00
5.445
-0.01
(-0.18%)
After-Hours: 20:00
Cormedix Gross Profit (Quarterly): 0.00 for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.0293M |
September 30, 2022 | 0.0053M |
June 30, 2022 | 0.0209M |
March 31, 2022 | 0.0061M |
December 31, 2021 | 0.0084M |
September 30, 2021 | 0.0129M |
June 30, 2021 | -0.0062M |
March 31, 2021 | 0.0269M |
December 31, 2020 | -0.0015M |
September 30, 2020 | 0.0131M |
June 30, 2020 | -0.0027M |
March 31, 2020 | 0.0255M |
December 31, 2019 | -0.0213M |
September 30, 2019 | -0.0195M |
June 30, 2019 | 0.0141M |
March 31, 2019 | -0.0633M |
December 31, 2018 | 0.0044M |
September 30, 2018 | 0.0601M |
June 30, 2018 | -0.0261M |
March 31, 2018 | -0.0054M |
December 31, 2017 | 0.1558M |
Date | Value |
---|---|
September 30, 2017 | -0.0056M |
June 30, 2017 | 0.1181M |
March 31, 2017 | -0.054M |
December 31, 2016 | 0.0364M |
September 30, 2016 | 0.0005M |
June 30, 2016 | -0.1707M |
March 31, 2016 | -0.0088M |
December 31, 2015 | -0.1413M |
September 30, 2015 | 0.0006M |
June 30, 2015 | 0.0182M |
March 31, 2015 | 0.0139M |
December 31, 2014 | -0.1887M |
September 30, 2014 | 0.0158M |
June 30, 2014 | -0.0147M |
March 31, 2014 | -0.0688M |
December 31, 2013 | -0.1996M |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-0.0213M
Minimum
Dec 2019
0.0293M
Maximum
Dec 2022
0.0059M
Average
0.0053M
Median
Sep 2022
Gross Profit (Quarterly) Benchmarks
BioXcel Therapeutics Inc | -0.338M |
Assertio Holdings Inc | 23.26M |
Verastem Inc | -- |
Ocular Therapeutix Inc | 13.42M |
PAVmed Inc | -0.562M |